Clinical Trial Update: VMAT for Dominant Intraprostatic Lesion [NA]

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating VMAT for a dominant intraprostatic lesion in prostate cancer, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2023-05-24